-
Twenty Percent Quarterly Profit Growth Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 6, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
No Comments
Five twenty percent quarterly profit growth stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Affle 3i, ICICI Bank, LIC, Sun Pharma and Time Techno.
-
3 Automotive Lighting Systems Maker, Global Pharmaceutical Company and Largest Pharmaceutical Company Stocks With a Strong Future Roadmap: Lumax Industries, Lupin and Sun Pharma
- November 6, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Auto Lighting, Global Pharma, Drug Major Stocks with a strong future roadmap: Lumax Industries, Lupin and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 5 November 2026.
-
Pharma and Healthcare Stocks: A Defensive Theme for Samvat 2083 After Nifty Pharma’s 21% Gain in Samvat 2082?
- November 5, 2026
- Posted by: Chaitanya Auti
- Category: Market
Nifty Pharma rose 21.4% in Samvat 2082. Are pharma and healthcare stocks still a defensive theme for Samvat 2083? Growth drivers, US tariffs and risks.
-
Under Rs 1900 Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 5, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Five under Rs 1900 stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Kalpataru Projects, Astral, Gravita India, Cholamandalam and Sun Pharma.
-
3 Private Hospital Network, Single Use Medical Devices Maker and Largest Pharma Company Stocks With a Strong Future Roadmap: Apollo Hospitals Enterprise, Poly Medicure and Sun Pharma
- November 4, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Hospital Chain, Medical Device and Pharma Stocks with a strong future roadmap: Apollo Hospitals Enterprise, Poly Medicure and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 3 November 2026.
-
Under Rs 2500 Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 4, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Five under Rs 2500 stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Bajaj Finserv, Sun Pharma, Adani Ports, Ipca Labs and Power Mech.
-
Mumbai Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 4, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Five Mumbai stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for L&T, Sun Pharma, Phoenix, Ajanta Pharma and Ipca Labs.
-
3 Multi Speciality Hospital Chain, Pathology and Diagnostics Company and Largest Pharma Company Stocks With a Strong Future Roadmap: Max Healthcare Institute, Metropolis Healthcare and Sun Pharma
- October 30, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Hospital, Pathology and Pharma Leader Stocks with a strong future roadmap: Max Healthcare Institute, Metropolis Healthcare and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.
-
3 India’s Largest Pharma Company, Complex Generics and Oncology Specialist and Branded Generics Maker Stocks With a Strong Future Roadmap: Sun Pharma, Natco Pharma and Lincoln Pharmaceuticals
- October 30, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Branded Generic and Oncology Drug Stocks with a strong future roadmap: Sun Pharma, Natco Pharma and Lincoln Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.